These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3332537)

  • 1. Modulation of prolactin responses to gonadotropin releasing hormone by acute testosterone infusions in normal women.
    Serafini P; Paulson RJ; Francis MM; Lobo RA
    Gynecol Endocrinol; 1987 Sep; 1(3):247-53. PubMed ID: 3332537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin response after gonadotropin-releasing hormone in the polycystic ovary syndrome.
    Shoupe D; Lobo RA
    Fertil Steril; 1985 Apr; 43(4):549-53. PubMed ID: 3921411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex steroid control of gonadotropin secretion in the human male. I. Effects of testosterone administration in normal and gonadotropin-releasing hormone-deficient men.
    Finkelstein JS; Whitcomb RW; O'Dea LS; Longcope C; Schoenfeld DA; Crowley WF
    J Clin Endocrinol Metab; 1991 Sep; 73(3):609-20. PubMed ID: 1908484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships among LH, FSH and prolactin secretion, storage and response to secretagogue and hypothalamic GnRH content in ovariectomized pony mares administered testosterone, dihydrotestosterone, estradiol, progesterone, dexamethasone or follicular fluid.
    Thompson DL; Garza F; St George RL; Rabb MH; Barry BE; French DD
    Domest Anim Endocrinol; 1991 Apr; 8(2):189-99. PubMed ID: 1906388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin-releasing action of a low dose of exogenous gonadotropin-releasing hormone throughout the human menstrual cycle.
    Mais V; Melis GB; Paoletti AM; Strigini F; Antinori D; Fioretti P
    Neuroendocrinology; 1986; 44(3):326-30. PubMed ID: 3100975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen dependence of the periovulatory plasma prolactin response to gonadotropin-releasing hormone in normal women.
    Barbarino A; De Marinis L; Mancini A; D'Amico C; Minnielli S
    Metabolism; 1983 Nov; 32(11):1059-62. PubMed ID: 6413811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function.
    Scott JZ; Kletzky OA; Brenner PF; Mishell DR
    Fertil Steril; 1978 Aug; 30(2):141-5. PubMed ID: 98356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary gonadotropin-releasing hormone (GnRH) receptor responses to GnRH in hypothalamus-lesioned rats: inhibition of responses by hyperprolactinemia and evidence that testosterone and estradiol modulate gonadotropin secretion at postreceptor sites.
    Pieper DR; Gala RR; Schiff MA; Regiani SR; Marshall JC
    Endocrinology; 1984 Sep; 115(3):1190-6. PubMed ID: 6086288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of physiological changes in ovarian steroids on the prolactin response to gonadotrophin releasing factor.
    Tan YM; Steele PA; Judd SJ
    Clin Endocrinol (Oxf); 1986 Jan; 24(1):71-8. PubMed ID: 3085991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of gonadotropin-releasing hormone and estradiol on luteinizing hormone and prolactin gene expression in female hypogonadal (hpg) mice.
    Saade G; London DR; Clayton RN
    Endocrinology; 1989 Apr; 124(4):1744-53. PubMed ID: 2538310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased gonadotropin responsiveness to gonadotropin-releasing hormone during fasting in normal subjects.
    Röjdmark S
    Metabolism; 1987 Jan; 36(1):21-6. PubMed ID: 3099123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for an altered luteinizing hormone sensitivity to naloxone in pathological hyperprolactinaemia.
    Larrea F; Sandoval JL; Salinas E; Franco-Rodriguez VA; Méndez I; Ulloa-Aguirre A
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):591-600. PubMed ID: 8548944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating prolactin and its response to TRH following administration of testosterone undecanoate in normal men.
    Kicovic PM; Luisi M; Franchi F; Krempl S
    J Endocrinol Invest; 1978 Oct; 1(4):359-61. PubMed ID: 117045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
    Sawin CT; Hershman JM; Boyd AE; Longcope C; Bacharach P
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synchronous secretion of luteinizing hormone and prolactin in the human luteal phase: neuroendocrine mechanisms.
    Braund W; Roeger DC; Judd SJ
    J Clin Endocrinol Metab; 1984 Feb; 58(2):293-7. PubMed ID: 6420434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex steroid control of gonadotropin secretion in the human male. II. Effects of estradiol administration in normal and gonadotropin-releasing hormone-deficient men.
    Finkelstein JS; O'Dea LS; Whitcomb RW; Crowley WF
    J Clin Endocrinol Metab; 1991 Sep; 73(3):621-8. PubMed ID: 1908485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catecholamines and pituitary-function. V. Effect of low-dose dopamine infusion on basal and gonadotropin-releasing hormone stimulated gonadotropin release in normal cycling women and patients with hyperprolactinemic amenorrhea.
    Nicoletti I; Ambrosi F; Giammartino C; Fedeli L; Mannarelli C; Filipponi P
    Horm Metab Res; 1986 Jul; 18(7):479-84. PubMed ID: 3091473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of luteal metoclopramide-induced hyperprolactinemia on pituitary and luteal responsiveness to gonadotropin-releasing hormone.
    Caruso A; Lanzone A; Fulghesu AM; Apa R; Guida C; Mancuso S
    Horm Res; 1989; 31(4):169-74. PubMed ID: 2507435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in the prolactin level under the effect of pulsatile infusion of gonadotropin releasing hormone].
    Koloszár S; Bártfai G; Sas M
    Orv Hetil; 1989 Jul; 130(27):1433-6. PubMed ID: 2501725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.